📊 AIFF Key Takeaways
Is Firefly Neuroscience, Inc.. (AIFF) a Good Investment?
Firefly Neuroscience exhibits a fundamentally unviable business model with only $485K in annual revenue while burning $1.9M in operating cash annually, providing approximately 1.6 years of cash runway before insolvency. Despite modest balance sheet strength and improving losses YoY, the company shows zero revenue growth and massive operating losses that indicate failed market traction in the prepackaged software sector.
Firefly Neuroscience shows very weak fundamentals: revenue is minimal and flat year over year, while operating and net losses are extraordinarily large relative to sales. Although the balance sheet is not heavily levered and near-term liquidity is still positive, current cash appears insufficient relative to ongoing cash burn, making the business highly dependent on external funding unless revenue scales materially.
Firefly Neuroscience, Inc.. Key Strengths (AIFF)
- Net income improved 19% YoY, indicating shrinking losses
- Strong liquidity with Current Ratio of 1.82x and Quick Ratio of 1.78x
- Conservative capital structure with Debt/Equity of 0.09x and low financial leverage
- Gross margin of 63.4% suggests the core product can generate reasonable unit-level economics at current scale
- Balance sheet leverage is low, with debt/equity of 0.08x and limited long-term debt
- Current and quick ratios near 2.0x indicate acceptable short-term liquidity at the latest reporting date
AIFF Stock Risks: Firefly Neuroscience, Inc.. Investment Risks
- Severe unit economics: $485K revenue against $1.9M operating cash burn annually is unsustainable
- Minimal cash runway of approximately 1.6 years at current burn rate before capital depletion
- Zero YoY revenue growth and near-zero revenue base indicate complete lack of market traction
- Revenue is only $730K and showed 0.0% YoY growth, indicating very weak commercial traction
- Operating loss of $6.36M and net loss of $17.40M versus tiny revenue reflect an unsustainable cost structure
- Operating cash flow of -$6.39M against $4.33M of cash implies funding risk and likely dilution or additional financing needs
Key Metrics to Watch
- Quarterly revenue growth acceleration - critical to achieve positive growth for viability
- Operating cash burn trajectory - must show significant deceleration or path to profitability
- Cash balance depletion rate - essential given limited runway before insolvency risk
- Revenue growth and customer adoption
- Quarterly operating cash burn versus cash balance
Firefly Neuroscience, Inc.. (AIFF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Firefly Neuroscience, Inc.. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
AIFF Profit Margin, ROE & Profitability Analysis
AIFF vs Technology Sector: How Firefly Neuroscience, Inc.. Compares
How Firefly Neuroscience, Inc.. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Firefly Neuroscience, Inc.. Stock Overvalued? AIFF Valuation Analysis 2026
Based on fundamental analysis, Firefly Neuroscience, Inc.. has mixed fundamental signals relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Firefly Neuroscience, Inc.. Balance Sheet: AIFF Debt, Cash & Liquidity
AIFF Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Firefly Neuroscience, Inc..'s revenue has declined by 92% over the 5-year period, indicating business contraction. The most recent EPS of $0.03 reflects profitable operations.
AIFF Revenue Growth, EPS Growth & YoY Performance
AIFF Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $43.0K | -$2.0M | N/A |
| Q3 2025 | $33.0K | -$1.1M | $-0.20 |
| Q2 2025 | $10.0K | -$1.1M | N/A |
| Q1 2025 | $12.0K | -$1.1M | N/A |
| Q3 2024 | $23.0K | -$650.0K | N/A |
| Q2 2024 | $1.9M | $234.8K | $0.36 |
| Q1 2024 | $1.9M | -$674.0K | N/A |
| Q3 2023 | $2.0M | -$149.9K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Firefly Neuroscience, Inc.. Dividends, Buybacks & Capital Allocation
AIFF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Firefly Neuroscience, Inc.. (CIK: 0000803578)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AIFF
What is the AI rating for AIFF?
Firefly Neuroscience, Inc.. (AIFF) has a Combined AI Grade of D from Claude (D) and ChatGPT (D) with 92% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AIFF's key strengths?
Claude: Net income improved 19% YoY, indicating shrinking losses. Strong liquidity with Current Ratio of 1.82x and Quick Ratio of 1.78x. ChatGPT: Gross margin of 63.4% suggests the core product can generate reasonable unit-level economics at current scale. Balance sheet leverage is low, with debt/equity of 0.08x and limited long-term debt.
What are the risks of investing in AIFF?
Claude: Severe unit economics: $485K revenue against $1.9M operating cash burn annually is unsustainable. Minimal cash runway of approximately 1.6 years at current burn rate before capital depletion. ChatGPT: Revenue is only $730K and showed 0.0% YoY growth, indicating very weak commercial traction. Operating loss of $6.36M and net loss of $17.40M versus tiny revenue reflect an unsustainable cost structure.
What is AIFF's revenue and growth?
Firefly Neuroscience, Inc.. reported revenue of $485.0K.
Does AIFF pay dividends?
Firefly Neuroscience, Inc.. does not currently pay dividends.
Where can I find AIFF SEC filings?
Official SEC filings for Firefly Neuroscience, Inc.. (CIK: 0000803578) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AIFF's EPS?
Firefly Neuroscience, Inc.. has a diluted EPS of $-1.81.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is AIFF's fundamental grade?
Based on our AI fundamental analysis in June 2026, Firefly Neuroscience, Inc.. has a D grade with 92% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is AIFF stock overvalued or undervalued?
Valuation metrics for AIFF: ROE of -23.7% (sector avg: 22%), net margin of -413.2% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
What is AIFF's AI grade for 2026?
Our dual AI analysis gives Firefly Neuroscience, Inc.. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AIFF's free cash flow?
Firefly Neuroscience, Inc..'s operating cash flow is $-1.9M, with capital expenditures of $0.0. FCF margin is -401.6%.
How does AIFF compare to other Technology stocks?
Vs Technology sector averages: Net margin -413.2% (avg: 18%), ROE -23.7% (avg: 22%), current ratio 1.82 (avg: 2.5).